VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen
Velia Chiara Di Maio(University of Rome Tor Vergata), Sergio Babudieri(University of Sassari), Miriam Lichtner(Sapienza University of Rome), Tiziano Allice(Ospedale Amedeo di Savoia), L. Donnarumma(University of Naples Federico II), Elisabetta Teti(University of Rome Tor Vergata), Roberto Gulminetti(University of Pavia), Laura Ambra Nicolini(Ospedale Policlinico San Martino), Bianca Bruzzone(Ospedale Policlinico San Martino), Vincenza Calvaruso(University of Palermo), Stefania Paolucci(Policlinico San Matteo Fondazione), Giovanni Cenderello(Ente Ospedaliero Ospedali Galliera), Maria Rendina, Simona Landonio(ASST Fatebenefratelli Sacco), M. Aragri(University of Rome Tor Vergata), Mario Starace(Vita-Salute San Raffaele University), C. Pasquazzi(Azienda Ospedaliera Sant'Andrea), S. Francioso, Ada Bertoli(IRCCS Policlinico San Donato), Ilaria Lenci, Ennio Polilli(Azienda USL di Pescara), Adriana Raddi(Ospedale di Belcolle), Hamid Hasson(Vita-Salute San Raffaele University), Ivana Maida, Vincenzo Sangiovanni(Ospedale Sant'Anna), Angelo Scuteri(University of Maryland, Baltimore), Vanni Borghi(University of Modena and Reggio Emilia), Chiara Masetti(NHS Blood and Transplant), Teresa Pollicino(University of Messina), P. Colombatto(Azienda Ospedaliera Universitaria Pisana), Alessia Ciancio(Department of Medical Sciences), Nunzia Cuomo(Federico II University Hospital), William Gennari(University of Modena and Reggio Emilia), Pietro Andreoné, Valeria Micheli(ASST Fatebenefratelli Sacco), Stefano Novati(Policlinico San Matteo Fondazione), Maurizia Rossana Brunetto(University of Pisa), Raffaele Cozzolongo, Giulia Morsica(Vita-Salute San Raffaele University), Elisabetta Degasperi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), A. De Santis(Sapienza University of Rome), Carmine Minichini(University of Campania "Luigi Vanvitelli"), Silvia Galli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Stefano Marenco(National Institutes of Health), Silvia Barbaliscia(University of Rome Tor Vergata), Enzo Boeri(National Cancer Institute), A.P. Callegaro(Ospedale Papa Giovanni XXIII), Filomena Morisco, Valeria Pace Palitti(Azienda USL di Pescara), Valeria Cento(Rostov State Medical University)
Cited by 1
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Searching for an Operational Definition of Frailty: A Delphi Method Based Consensus Statement. The Frailty Operative Definition-Consensus Conference Project
|The Journals of Gerontology Series A|2012|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664